ProCE Banner Activity

Express Points
AL Amyloidosis: Advances in Early Diagnosis, Treatment Options, and Individualized Care

Slideset Download
Downloadable summary slideset on the key takeaways from a live symposium on diagnosing and typing AL amyloidosis, and managing newly diagnosed and relapsed/refractory disease.

Released: December 16, 2022

Expiration: December 15, 2023

Begin Activity

Share

Faculty

Angela Dispenzieri

Angela Dispenzieri, MD

Serene and Francis During Named Professor
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, Minnesota

Anita D Souza

Anita D Souza, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Attending Physician
Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin

Jeffrey Zonder

Jeffrey Zonder, MD

Professor of Oncology  
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Alexion Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Program Director Disclosure

Program Director

Angela Dispenzieri, MD

Serene and Francis During Named Professor
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, Minnesota

Faculty Disclosure

Primary Author

Anita D Souza, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Attending Physician
Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin

Anita D’Souza, MD: consultant/advisor/speaker: Bristol-Myers Squibb, Janssen, Prothena; researcher: AbbVie, Caelum, Janssen, Prothena, Regeneron, Sanofi, Takeda, TeneoBio.

Jeffrey Zonder, MD

Professor of Oncology  
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Jeffrey Zonder, MD: consultant/advisor/speaker: Caelum/AstraZeneca, Intellia, Janssen, Prothena, Regeneron, Takeda; researcher: Bristol-Myers Squib